Melissa Reisinger, MD
Obstetrics & Gynecology · Newburgh, INNPI 1831194406
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 260 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2023 at $1,298 and has fallen 59.8% since, to $522 in 2025. Among obstetrics & gynecology clinicians in IN with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 260 payments — averaging $18.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$956
- Biogen$435
- Sumitomo Pharma America, Inc.$364
- Daiichi Sankyo Inc.$326
- Pfizer$288
- Mayne Pharma Commercial LLC$210
- plus $2K from 32 others
What the payments were for
- Food & beverage$4,867100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 59 | $956 |
| Biogen | 17 | $435 |
| Sumitomo Pharma America, Inc. | 20 | $364 |
| Daiichi Sankyo Inc. | 11 | $326 |
| Pfizer | 18 | $288 |
| Mayne Pharma Commercial LLC | 13 | $210 |
| Avion Pharmaceuticals | 17 | $206 |
| Aspira Women's Health Inc | 3 | $199 |
| Bayer | 11 | $157 |
| Astellas Pharma US Inc | 9 | $154 |
| Shield Therapeutics Inc | 8 | $149 |
| Medical Device Business Services, Inc. | 2 | $144 |
| Myovant Sciences Inc. | 8 | $144 |
| Medtronic | 3 | $137 |
| Amgen | 8 | $127 |
| Agile Therapeutics, Inc. | 8 | $124 |
| Hologic Sales And Service, LLC | 6 | $91 |
| Ascend Therapeutics US, LLC | 3 | $75 |
| Johnson & Johnson | 4 | $72 |
| Merck | 5 | $68 |
| Novo Nordisk | 1 | $62 |
| Sage Therapeutics, LLC | 3 | $55 |
| Organon | 4 | $40 |
| Pacira Pharmaceuticals Incorporated | 2 | $36 |
| Gynesonics, Inc. | 1 | $32 |
| Duchesnay USA Incorporated | 2 | $31 |
| Therapeuticsmd, Inc. | 2 | $23 |
| Vertical Pharmaceuticals, LLC | 2 | $22 |
| Covidien LP | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Exeltis, USA Inc. | 1 | $15 |
| Avanos Medical | 1 | $14 |
| Olympus America Inc. | 1 | $13 |
| Urovant Sciences Inc | 1 | $13 |
| Exact Sciences | 1 | $13 |
| Inari Medical, Inc. | 1 | $12 |
| Scynexis, Inc. | 1 | $12 |
| Meditrina | 1 | $8 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ENSEAL Product Family$113
- INJECTAFER$100
How this compares
$4,867 in reported general payments places this provider in the 90th percentile of 743 obstetrics & gynecology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 22 | $12,066 |
| ImvexxyEstradiol | 12 | $4,123 |
| YuvafemEstradiol | 21 | $2,635 |
| Estradiol (Once Weekly)Estradiol | 28 | $2,080 |
| Estradiol | 28 | $2,045 |
| Estradiol (Twice Weekly)Estradiol | 22 | $1,127 |
| Betamethasone Valerate | 12 | $265 |
| ValacyclovirValacyclovir Hcl | 18 | $241 |
| Levothyroxine Sodium | 22 | $100 |
| Fluconazole | 11 | $48 |
| Zolpidem Tartrate | 19 | $13 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $288 | $12,06622 claims |
| Therapeuticsmd, Inc.Imvexxy | $23 | $4,12312 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 743 obstetrics & gynecology providers in Indiana.
Other obstetrics & gynecology in Newburgh
- Paul MorrisonNewburgh$38K
- Constantine ScordalakesNewburgh$22K
- Charles WernerNewburgh$15K
- Marcia CaveNewburgh$9K
- Allen WalkerNewburgh$8K
- Kimberly FosterNewburgh$6K
- Ashley ScottFort Wayne$124K
- Candace WestgateIndianapolis$123K
- Keith RamseyLake Station$116K
- Stefanie FloraCarmel$106K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.